M. Ali

Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice.

G. Farr, Z. Tang, J. Gill, 2000, Journal of the National Cancer Institute.

The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.

J. Shellito, G. Bagby, D. Stoltz, 1998, Alcoholism, clinical and experimental research.

Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization

A. Futerman, Y. Pewzner‐Jung, J. Fritsch, 2013, Cell Death and Disease.

The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice.

B. Joshi, S. Flores, O. Prakash, 1997, Archives of biochemistry and biophysics.

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy

B. Telfer, P. Julyan, I. Stratford, 2010, British Journal of Cancer.